Advertisement
Home Tags Cancer: Breast

Tag: Cancer: Breast

The drug combination of lapatinib (Tykerb) and trastuzumab (Herceptin) induces tumor regression or disappearance in 25 percent of human epidermal growth factor receptor 2 (HER2)-positive cancers in 11 days

Lapatinib + Trastuzumab May Rapidly Shrink Breast Tumors

0
Researchers say combo therapy works well for about one in four women with HER2+ breast cancer
For women with early-stage breast cancer

Targeted Radiation Shows Promise in Early Breast Cancer

0
Limited radiotherapy effective after low-risk tumors are removed, but questions remain
For women with mammography-negative dense breasts

Breast Cancer Detection With Ultrasound Tops Tomosynthesis

0
False-positive recall rate similar; findings in women with mammography-negative dense breasts
Presurgery high neutrophil to lymphocyte ratio is a prognostic variable of worse outcome in Caucasian patients with early breast cancer

High Neutrophil to Lymphocyte Ratio Prognostic in Breast Cancer

0
High NLR linked to worse prognosis in Caucasian patients with early breast cancer
Many women treated for early breast cancer overestimate the odds of distant recurrence

Women Often Overestimate Odds of Early Breast Cancer Spreading

0
Misperceptions lead to worry that harms quality of life, researcher says
From 2005 to 2013 there was a 36 percent increase in the overall rate of mastectomies

Thirty-Six Percent Increase in Mastectomies From 2005 to 2013

0
Bilateral mastectomies with cancer more than tripled and those without cancer more than doubled
Use of vaginal estrogen should be carefully considered by women with a history of estrogen-dependent breast cancer

ACOG: Vaginal Estrogen Can Be Used for Breast Cancer Survivors

0
Decision to use vaginal estrogen should be made with oncologist, after consideration of data
Quality of life after a ductal carcinoma in situ diagnosis is generally comparable to that of similarly aged women without the diagnosis

Quality of Life After DCIS Diagnosis Doesn’t Decline

0
At two years after diagnosis, physical, mental measures same as non-cancer patients
Exercise does not appear to result in significant improvements in physical functioning in women living with advanced breast cancer

Exercise No Aid to Functioning With Advanced Breast Cancer

0
Intervention didn't increase weekly exercise or physical functioning
Some women aged 40 to 49 years with estrogen receptor-positive breast cancer who undergo chemotherapy-induced amenorrhea regain ovarian function with letrozole

Letrozole Tied to Ovarian Function Recovery in Chemo

0
Findings in women aged 40 to 49 years with estrogen receptor-positive breast cancer